Aetna's Closed Part D Formulary Limits Drug Access, CMS Says
Drug access problems stemming from Aetna's change in 2010 from an open formulary to a more restrictive closed one in many of its Medicare Part D plans has drawn sanctions from the Centers for Medicare and Medicaid Services
You may also be interested in...
Part D status in MedPAC report to Congress: Ninety percent of Medicare beneficiaries had some sort of prescription drug coverage as of January 2010, the Medicare Payment Advisory Commission says in its annual report to Congress, released March 1. The report includes a discussion of the status of Part D, where it is noted that among Medicare beneficiaries, 59 percent receive drug benefits through a Part D drug plan and 32 percent have drug coverage that is at least as generous as Part D through an employer or other source. While the number of stand-alone drug plans declined 7 percent in 2010, beneficiaries in each coverage region still have from 41 to 55 plan choices; 317 premium-free plans are available to enrollees who receive the low-income subsidy
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials